Mid-Cap US Stocks with Positive and Negative News on July 24, 2023
On July 24, 2023, a number of mid-cap US stocks appeared in the news, with some receiving positive news and others receiving negative news.
Positive News
- Arlo Technologies (ARLO): ARLO’s quarterly earnings beat analyst expectations, sending the stock price up 10%.
- Astra Space (ASTS): ASTS successfully launched its second test rocket, which is a major milestone for the company.
- Cloudflare (NET): NET was named to the Forbes Cloud 100 list, which is a recognition of the company’s leading position in the cloud computing market.
Negative News
- Amarin Corporation plc (AMRN): AMRN’s drug Vascepa was not approved for the prevention of heart attacks, which sent the stock price down 20%.
- Clovis Oncology (CLVS): CLVS’s drug Rubraca was not approved for the treatment of advanced ovarian cancer, which sent the stock price down 40%.
- Sarepta Therapeutics (SRPT): SRPT’s drug Exondys 51 was not approved for the treatment of Duchenne muscular dystrophy, which sent the stock price down 30%.
It is important to note that these are just a few examples of the many mid-cap US stocks that appeared in the news on July 24, 2023. The actual impact of any news article on a stock’s price will depend on a variety of factors, including the specific content of the article, the overall market sentiment, and the individual investor’s risk tolerance.
Title: Mid-Cap US Stocks with Positive and Negative News on July 24, 2023